This HTML5 document contains 47 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
n9http://dx.doi.org/10.1093/EURJHF/
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q83433276
rdf:type
wikibase:Item
schema:description
scientific article published on 17 February 2011 artículu científicu espublizáu en febreru de 2011 наукова стаття, опублікована в лютому 2011 wetenschappelijk artikel im Februar 2011 veröffentlichter wissenschaftlicher Artikel article scientifique publié en 2011
p:P577
wds:Q83433276-6F621FBB-C1A2-40FA-BF2E-794B7F1F6C83
wdt:P577
2011-02-17T00:00:00Z
rdfs:label
Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy
skos:prefLabel
Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy
schema:name
Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy
p:P50
wds:Q83433276-B3FF712C-1295-4D03-B65F-034597CF9EED wds:Q83433276-D3AE00C6-1135-4B8F-8611-B493C3605627 wds:Q83433276-DF78D17B-2991-45EF-8F15-D87670E36D0A wds:Q83433276-E020B1AE-EB77-4EC6-B468-4F378A95AACD wds:Q83433276-3F8CCAEE-7071-4B50-90B4-581EA5306EAD wds:Q83433276-5BA59DF7-AB7C-416E-90C9-15117E638808
wdt:P50
wd:Q110910889 wd:Q110902966 wd:Q92209152 wd:Q91827926 wd:Q110909269 wd:Q95921326
p:P1476
wds:Q83433276-C6CDE9D1-EEB1-4320-9DD7-ECBC3CE3F6BB
wdt:P1476
Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy
p:P304
wds:Q83433276-DC5A87C3-8F4F-4D29-9640-BF7C7B549F71
wdt:P304
543-550
p:P31
wds:Q83433276-7B5B616F-AD48-4E9C-978F-CFC2E138BB2D
wdt:P31
wd:Q13442814
p:P921
wds:Q83433276-7CD37F56-06F6-4B98-9F35-189707A3B545
wdt:P921
wd:Q815819
p:P698
wds:Q83433276-B0A7D847-9586-44D7-A8AC-A70C908974D0
wdtn:P698
n12:21330294
wdt:P698
21330294
p:P1433
wds:Q83433276-EB60743D-A93C-49BA-A8AF-849F12BF8A09
wdt:P1433
wd:Q5017954
p:P433
wds:Q83433276-928EA472-6681-407A-9974-588D92C7E34E
p:P478
wds:Q83433276-D9DC2391-1136-44B6-B244-066D1AB9BF4D
wdt:P433
5
wdt:P478
13
p:P356
wds:Q83433276-DB7F2349-906F-48EB-A47A-4662E3F025E4
wdtn:P356
n9:HFR006
wdt:P356
10.1093/EURJHF/HFR006